The effect of remote ischemic conditioning and glyceryl trinitrate on perioperative myocardial injury in cardiac bypass surgery patients: Rationale and design of the ERIC-GTN study

Clinical Cardiology

Volumn 38, Issue 11, 2015, Pages 641-646

  Hamarneh, Ashraf ^a   Sivaraman, Vivek ^a   Bulluck, Heerajnarain ^a   Shanahan, Hilary ^b   Kyle, Bonnie ^b   Ramlall, Manish ^a   Chung, Robin ^a   Jarvis, Claire ^b   Xenou, Maria ^b   Ariti, Cono ^c   Cordery, Roger ^a   Yellon, Derek M ^a   Hausenloy, Derek J ^a,d,e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c Health Education England   (United Kingdom)

^d DEPARTMENT OF CARDIOLOGY   (Singapore)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; PLACEBO; TROPONIN T; BIOLOGICAL MARKER; VASODILATOR AGENT;

ADULT; ANESTHESIA INDUCTION; ARM; ARTICLE; CARDIOPLEGIA; CLINICAL PROTOCOL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INFUSION; ELECTIVE SURGERY; FEMALE; HEART MUSCLE INJURY; HEART PROTECTION; HEART VALVE SURGERY; HUMAN; ISCHEMIC PRECONDITIONING; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REMOTE ISCHEMIC CONDITIONING; REPERFUSION INJURY; SHAM PROCEDURE; SURGICAL PATIENT; THERAPY EFFECT; THIGH; ADVERSE EFFECTS; AGED; BLOOD; BLOOD FLOW; ENGLAND; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MYOCARDIAL REPERFUSION INJURY; PROCEDURES; TIME FACTOR; TREATMENT OUTCOME; UPPER LIMB; VASCULARIZATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS; CLINICAL PROTOCOLS; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; ISCHEMIC PRECONDITIONING; LONDON; MALE; MIDDLE AGED; MYOCARDIAL REPERFUSION INJURY; NITROGLYCERIN; REGIONAL BLOOD FLOW; RESEARCH DESIGN; THIGH; TIME FACTORS; TREATMENT OUTCOME; TROPONIN T; UPPER EXTREMITY; VASODILATOR AGENTS;

EID: 84955206646     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22445     Document Type: Article

References (28)

1. Venugopal V, Ludman A, Yellon DM, et al., 'Conditioning' the heart during surgery [published correction appears in Eur J Cardiothorac Surg. 2009;36:608]. Eur J Cardiothorac Surg. 2009; 35: 977-987.
2. Hausenloy DJ, Boston-Griffiths E, Yellon DM,. Cardioprotection during cardiac surgery. Cardiovasc Res. 2012; 94: 253-265.
3. Przyklenk K, Bauer B, Ovize M, et al., Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 1993; 87: 893-899.
4. Hausenloy DJ, Yellon DM,. Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res. 2008; 79: 377-386.
5. Hausenloy DJ, Mwamure PK, Venugopal V, et al., Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet. 2007; 370: 575-579.
6. Thielmann M, Kottenberg E, Boengler K, et al., Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest. Basic Res Cardiol. 2010; 105: 657-664.
7. Candilio L, Malik A, Ariti C, et al., Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial. Heart. 2015; 101: 185-192.
8. Karuppasamy P, Chaubey S, Dew T, et al., Remote intermittent ischemia before coronary artery bypass graft surgery: a strategy to reduce injury and inflammation? Basic Res Cardiol. 2011; 106: 511-519.
9. Rahman IA, Mascaro JG, Steeds RP, et al., Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment? Circulation. 2010; 122 (11 suppl): S53-S59.
10. Ferdinandy P, Hausenloy DJ, Heusch G, et al., Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Pharmacol Rev. 2014; 66: 1142-1174.
11. Hausenloy DJ, Erik Bøtker H, Condorelli G, et al., Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res. 2013; 98: 7-27.
12. Sivaraman V, Pickard JM, Hausenloy DJ,. Remote ischaemic conditioning: from academic curiosity to clinical reality [published online ahead of print February 26, 2015]. Anaesthesia. doi: 10.1111/anae.12973.
13. Kottenberg E, Thielmann M, Bergmann L, et al., Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol-a clinical trial. Acta Anaesthesiol Scand. 2012; 56: 30-38.
14. Kottenberg E, Musiolik J, Thielmann M, et al., Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2014; 147: 376-382.
15. Muntean DM, Ordodi V, Ferrera R, et al., Volatile anaesthetics and cardioprotection: lessons from animal studies. Fundam Clin Pharmacol. 2013; 27: 21-34.
16. Pagliaro P, Gattullo D, Penna C,. Nitroglycerine and sodium trioxodinitrate: from the discovery to the preconditioning effect. J Cardiovasc Med (Hagerstown). 2013; 14: 698-704.
17. Ko WJ, Lin CY, Chen RJ, et al., Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock. Ann Thorac Surg. 2002; 73: 538-545.
18. Kellum JA, Lameire N,; KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1). Crit Care. 2013; 17: 204.
19. Hettmansperger TP, Elmore R,. Rank tests for interaction: should they be taught in a nonparametric course? Sixth International Conference on the Teaching of Statistics; July 12, 2002; Cape Town, South Africa.
20. White IR, Horton NJ, Carpenter J, et al., Strategy for intention-to-treat analysis in randomised trials with missing outcome data. BMJ. 2011; 342: d40.
21. Harris PA, Taylor R, Thielke R, et al., Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009; 42: 377-381.
22. Kleinbongard P, Thielmann M, Jakob H, et al., Nitroglycerin does not interfere with protection by remote ischemic preconditioning in patients with surgical coronary revascularization under isoflurane anesthesia. Cardiovasc Drugs Ther. 2013; 27: 359-361.
23. Yellon DM, Downey JM,. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev. 2003; 83: 1113-1151.
24. Petrishchev NN, Vlasov TD, Sipovsky VG, et al., Does nitric oxide generation contribute to the mechanism of remote ischemic preconditioning? Pathophysiology. 2001; 7: 271-274.
25. Xiao L, Lu R, Hu CP, et al., Delayed cardioprotection by intestinal preconditioning is mediated by calcitonin gene-related peptide. Eur J Pharmacol. 2001; 427: 131-135.
26. Zweier JL, Samouilov A, Kuppusamy P,. Non-enzymatic nitric oxide synthesis in biological systems. Biochim Biophys Acta. 1999; 1411: 250-262.
27. Rassaf T, Totzeck M, Hendgen-Cotta UB, et al., Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning. Circ Res. 2014; 114: 1601-1610.
28. Steensrud T, Li J, Dai X, et al., Pretreatment with the nitric oxide donor SNAP or nerve transection blocks humoral preconditioning by remote limb ischemia or intra-arterial adenosine. Am J Physiol Heart Circ Physiol. 2010; 299: H1598-H1603.